We are live on ! Find out more
BI

BVF Inc Portfolio holdings

AUM $3.14B
1-Year Est. Return 249.53%
This Fund
S&P 500
This Quarter Est. Return
+38.64%
1 Year Est. Return
+249.53%
3 Year Est. Return
+690.11%
5 Year Est. Return
+1,011.36%
10 Year Est. Return
+22,702.25%
AUM
$2.54B
AUM Growth
+$706M
Cap. Flow
+$104M
Cap. Flow %
4.08%
Top 10 Hldgs %
54.04%
Holding
74
New
12
Increased
16
Reduced
23
Closed
6

Top Buys

1
OLMA icon
Olema Pharmaceuticals
OLMA
+$312M
2
AMRN
Amarin Corp
AMRN
+$46.6M
3
FDMT icon
4D Molecular Therapeutics
FDMT
+$45.7M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$40.9M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$31.4M

Top Sells

1
SWTX
SpringWorks Therapeutics
SWTX
+$132M
2
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$87.3M
3
CLDX icon
Celldex Therapeutics
CLDX
+$45.5M
4
REPL icon
Replimune Group
REPL
+$38.9M
5
XNCR icon
Xencor
XNCR
+$33.2M

Sector Composition

1 Healthcare 98.24%
2 Financials 0.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBIO
26
Crescent Biopharma
CBIO
$432M
$35.9M 1.41%
95,443
+23,000
+32% +$8.06M
FBRX icon
27
Forte Biosciences
FBRX
$904M
$26.2M 1.03%
28,752
-2,350
-8% -$2.21M
CALT
28
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$25.5M 1%
750,000
– –
VSTM icon
29
Verastem
VSTM
$504M
$23.8M 0.94%
931,750
+36,084
+4% +$725K
IMVT icon
30
Immunovant
IMVT
$8.19B
$23.8M 0.93%
514,370
-684,057
-57% -$31.6M
CTIC
31
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$22.3M 0.88%
6,929,690
– –
CALA
32
DELISTED
Calithera Biosciences, Inc
CALA
$21.4M 0.84%
218,062
-11,220
-5% -$983K
MTEM
33
DELISTED
Molecular Templates, Inc.
MTEM
$20.2M 0.79%
143,270
– –
SNDX icon
34
Syndax Pharmaceuticals
SNDX
$2.08B
$19.5M 0.77%
878,524
-1,592,154
-64% -$33M
ARGX icon
35
argenx
ARGX
$54B
$18.4M 0.72%
62,491
-107,109
-63% -$29.4M
FPRX
36
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$17.7M 0.7%
1,038,678
-6,970,675
-87% -$87.3M
COGT icon
37
Cogent Biosciences
COGT
$6.72B
$17.2M 0.68%
+1,532,282
New +$16.8M
PVLA
38
Palvella Therapeutics
PVLA
$2.18B
$13.7M 0.54%
68,682
– –
PNT
39
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$13.3M 0.52%
954,996
-45,004
-5% -$625K
ELDN icon
40
Eledon Pharmaceuticals
ELDN
$310M
$11.8M 0.46%
763,279
+567,953
+291% +$10.8M
GMDA
41
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$11.3M 0.44%
1,343,667
-800,000
-37% -$5.41M
LITS
42
Lite Strategy Inc
LITS
$33.7M
$10.7M 0.42%
202,458
-1,550
-0.8% -$89.4K
GRTS
43
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$10.6M 0.42%
+2,695,418
New +$8.15M
OVID icon
44
Ovid Therapeutics
OVID
$465M
$10.4M 0.41%
4,522,051
+900,000
+25% +$4.19M
RNAC icon
45
Cartesian Therapeutics
RNAC
$255M
$10M 0.39%
110,165
-171,820
-61% -$14.9M
GNCA
46
DELISTED
Genocea Biosciences, Inc.
GNCA
$9.71M 0.38%
4,012,404
– –
TNGX icon
47
Tango Therapeutics
TNGX
$4.93B
$9.15M 0.36%
800,000
– –
CFRX
48
DELISTED
ContraFect Corporation
CFRX
$8.08M 0.32%
20,000
– –
CDTX
49
DELISTED
Cidara Therapeutics
CDTX
$7.48M 0.29%
186,985
-1,350
-0.7% -$67.1K
CRVS icon
50
Corvus Pharmaceuticals
CRVS
$1.25B
$6.92M 0.27%
1,943,712
+200,000
+11% +$805K
1
2
3

Similar funds

GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.13B AUM 41.22% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.15B AUM 20.31% 1-Year Est. Return
EAM
EULAV Asset Management Sarasota, Florida $3.12B AUM 13.38% 1-Year Est. Return
SCM
Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $3.12B AUM 21% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.12B AUM 22.88% 1-Year Est. Return